SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Vitamin E May Slash Lung Cancer Risk, University of Texas MD Anderson Cancer Center Study
November 3, 2008
 · 
1 min read
Drug Development
Rare Cancer Requires Support From Immune System To Develop, University of Texas Southwestern Medical Center Study
October 31, 2008
 · 
1 min read
BioCapital
National Institutes of Health (NIH) Release: University of Texas Southwestern Medical Center And Indiana University School of Medicine Researchers Identify Mechanism And Possible Drug Treatment For Growth Of Nerve Tumors In Neurofibromatosis
October 31, 2008
 · 
5 min read
Lone Star Bio
Insulin, Light Treatment Therapies May Not Help Preemies, University of Cambridge Study And University of Texas Medical School Study
October 30, 2008
 · 
1 min read
Lone Star Bio
Exploring Use Of Fat Cells As Heart Attack Therapy, University of Houston Study
October 29, 2008
 · 
1 min read
Drug Development
New Optimer Pharmaceuticals, Inc. Drug Treats Traveler’s Diarrhea, University of Texas Study
October 29, 2008
 · 
1 min read
Biotech Bay
BioPharm Executive: No Free Lunch
October 29, 2008
 · 
2 min read
Drug Development
Steroids Aid Recovery From Pneumonia, UT Southwestern Medical Center Researchers Say
October 20, 2008
 · 
1 min read
Lone Star Bio
Brazilian Acai Berry Antioxidants Absorbed By Human Body, University of Texas Research Shows
October 17, 2008
 · 
1 min read
Lone Star Bio
Scientists Use Light To Control Proteins, Penn State University And University of Texas Southwestern Medical Center Study
October 17, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
January 15, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
January 15, 2026
 · 
5 min read
Press Releases
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
January 14, 2026
 · 
6 min read
Press Releases
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 13, 2026
 · 
1 min read
Press Releases
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
January 13, 2026
 · 
7 min read
Press Releases
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
January 13, 2026
 · 
9 min read
Press Releases
TYBR Health Appoints Jeff Tyber to Board of Directors
January 13, 2026
 · 
2 min read
Press Releases
Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity
January 13, 2026
 · 
6 min read
Press Releases
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 13, 2026
 · 
7 min read
Press Releases
Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs
January 13, 2026
 · 
10 min read
Load More